Business
Ilumira authorization opens EU route for SHINE Lu-177
The EMA-authorized radiopharmaceutical precursor is produced at SHINE’s Cassiopeia facility in Wisconsin for use in radiolabelling carrier medicines.
Company
European Medicines Agency
Company
The EMA-authorized radiopharmaceutical precursor is produced at SHINE’s Cassiopeia facility in Wisconsin for use in radiolabelling carrier medicines.